The Parkinson Disease Protein Leucine-Rich Repeat Kinase 2 Transduces Death Signals via Fas-Associated Protein with Death Domain and Caspase-8 in a Cellular Model of Neurodegeneration

被引:124
作者
Ho, Cherry Cheng-Ying [1 ,2 ]
Rideout, Hardy J. [1 ]
Ribe, Elena [1 ,2 ]
Troy, Carol M. [1 ,2 ,4 ]
Dauer, William T. [1 ,3 ]
机构
[1] Columbia Univ, Dept Neurol, New York, NY 10032 USA
[2] Columbia Univ, Dept Pathol, New York, NY 10032 USA
[3] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA
[4] Columbia Univ, Taub Ctr Study Alzheimers Dis & Aging Brain, New York, NY 10032 USA
关键词
Parkinson's disease; apoptosis; neuronal apoptosis; neuronal death; neuron death; caspase; NF-KAPPA-B; DOPAMINERGIC-NEURONS; LRRK2; APOPTOSIS; MUTATIONS; ACTIVATION; MECHANISMS; TOXICITY; NECROSIS; GTPASE;
D O I
10.1523/JNEUROSCI.5175-08.2009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurodegenerative illnesses such as Parkinson and Alzheimer disease are an increasingly prevalent problem in aging societies, yet no therapies exist that retard or prevent neurodegeneration. Dominant missense mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson disease (PD), but the mechanisms by which mutant forms of LRRK2 disrupt neuronal function and cause cell death remain poorly understood. We report that LRRK2 interacts with the death adaptor Fas-associated protein with death domain (FADD), and that in primary neuronal culture LRRK2-mediated neurodegeneration is prevented by the functional inhibition of FADD or depletion of caspase-8, two key elements of the extrinsic cell death pathway. This pathway is activated by disease-triggering mutations, which enhance the LRRK2-FADD association and the consequent recruitment and activation of caspase-8. These results establish a direct molecular link between a mutant PD gene and the activation of programmed cell death signaling, and suggest that FADD/caspase-8 signaling contributes to LRRK2-induced neuronal death.
引用
收藏
页码:1011 / 1016
页数:6
相关论文
共 39 条
  • [1] A unified model for apical caspase activation
    Boatright, KM
    Renatus, M
    Scott, FL
    Sperandio, S
    Shin, H
    Pedersen, IM
    Ricci, JE
    Edris, WA
    Sutherlin, DP
    Green, DR
    Salvesen, GS
    [J]. MOLECULAR CELL, 2003, 11 (02) : 529 - 541
  • [2] LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-Linking familial and sporadic Parkinson's disease
    Bonifati, Vincenzo
    [J]. NEUROCHEMICAL RESEARCH, 2007, 32 (10) : 1700 - 1708
  • [3] Immune signalling in neural development, synaptic plasticity and disease
    Boulanger, LM
    Shatz, CJ
    [J]. NATURE REVIEWS NEUROSCIENCE, 2004, 5 (07) : 521 - 531
  • [4] Axonal dynactin p150Glued transports caspase-8 to drive retrograde olfactory receptor neuron apoptosis
    Carson, C
    Saleh, M
    Fung, FW
    Nicholson, DW
    Roskams, AJ
    [J]. JOURNAL OF NEUROSCIENCE, 2005, 25 (26) : 6092 - 6104
  • [5] Atypical role of proximal caspase-8 in truncated Tau-induced neurite regression and neuronal cell death
    Chung, CW
    Hong, YM
    Song, SM
    Woo, HN
    Choi, YH
    Rohn, T
    Jung, YK
    [J]. NEUROBIOLOGY OF DISEASE, 2003, 14 (03) : 557 - 566
  • [6] How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease
    Cookson, MR
    Xiromerisiou, G
    Singleton, A
    [J]. CURRENT OPINION IN NEUROLOGY, 2005, 18 (06) : 706 - 711
  • [7] Caspase-3 and caspase-9 mediate developmental apoptosis in the mouse olfactory system
    Cowan, CM
    Roskams, AJ
    [J]. JOURNAL OF COMPARATIVE NEUROLOGY, 2004, 474 (01) : 136 - 148
  • [8] Parkinson's disease: Mechanisms and models
    Dauer, W
    Przedborski, S
    [J]. NEURON, 2003, 39 (06) : 889 - 909
  • [9] Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation
    Davidson, TJ
    Harel, S
    Arboleda, VA
    Prunell, GF
    Shelanski, ML
    Greene, LA
    Troy, CM
    [J]. JOURNAL OF NEUROSCIENCE, 2004, 24 (45) : 10040 - 10046
  • [10] AGING AND PARKINSONS-DISEASE - SUBSTANTIA-NIGRA REGIONAL SELECTIVITY
    FEARNLEY, JM
    LEES, AJ
    [J]. BRAIN, 1991, 114 : 2283 - 2301